EA
Schedule 13G filing
Empery Asset Management, LP cut its Lantern Pharma Inc. (LTRN) stake below 5%
Empery Asset Management, LP reported owning 5% of Lantern Pharma Inc. (LTRN) (755,891 shares) in a Schedule 13G filed Oct 13, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
More LTRN insider and Congress trades
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.